Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsAngiogenesis InhibitorsDoxorubicinCyclophosphamideCombined Modality TherapyOsteosarcomaCisplatinDisease-Free SurvivalVincristineTreatment OutcomeChemotherapy, AdjuvantPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaNeovascularization, PathologicRetrospective StudiesNeoplasmsEndostatinsClinical ProtocolsAntineoplastic Agents, PhytogenicCell Line, TumorVascular Endothelial Growth Factor AXenograft Model Antitumor AssaysAntibiotics, AntineoplasticBreast NeoplasmsMice, NudeLung NeoplasmsPaclitaxelAntineoplastic Agents, AlkylatingEtoposideAngiostatinsThrombospondin 1Drug Administration ScheduleNeoadjuvant TherapyDrug Resistance, NeoplasmAntimetabolites, AntineoplasticDose-Response Relationship, DrugSurvival AnalysisApoptosisMethotrexateAntibodies, Monoclonal, HumanizedSurvival RateDrug Screening Assays, AntitumorNeoplasm StagingEndothelial CellsTime FactorsCell ProliferationNeoplasm TransplantationBrain NeoplasmsVascular Endothelial Growth Factor Receptor-2TaxoidsVinblastineTumor Cells, CulturedNeovascularization, PhysiologicPyrrolesNeoplasm MetastasisDeoxycytidineCarboplatinOvarian NeoplasmsBleomycinDrug SynergismReceptors, Vascular Endothelial Growth FactorNeoplasm Recurrence, LocalCyclohexanesChorioallantoic MembraneAdenocarcinomaCell DivisionClinical Trials as TopicIfosfamideCytarabineCell SurvivalAntibodies, MonoclonalOrganoplatinum CompoundsNeoplasms, ExperimentalInduction ChemotherapyEndothelium, VascularCarcinoma, Non-Small-Cell LungVascular Endothelial Growth Factor Receptor-1AnthracyclinesColorectal NeoplasmsMice, SCIDCamptothecinCorneal NeovascularizationFollow-Up StudiesTumor BurdenIndolesDaunorubicinSesquiterpenesColonic NeoplasmsMice, Inbred BALB CImmunohistochemistryCarmustineLiver NeoplasmsDacarbazineGlioblastomaGliomaAngiogenic ProteinsMelanoma, ExperimentalThalidomideVomiting